Construction and validation of N6-methyladenosine long non-coding RNAs signature of prognostic value for early biochemical recurrence of prostate cancer-Reference-Cited by-同舟云学术

Construction and validation of N6-methyladenosine long non-coding RNAs signature of prognostic value for early biochemical recurrence of prostate cancer

Published:2022-06-22 Issue:5 Volume:149 Page:1969-1983
ISSN:0171-5216
Container-title:Journal of Cancer Research and Clinical Oncology
language:en
Short-container-title:J Cancer Res Clin Oncol

Author:

Liu Jingchao,Zhang Wei,Wang Jiawen,Lv Zhengtong,Xia Haoran,Zhang Zhipeng,Zhang Yaoguang,Wang Jianye

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00432-022-04040-y.pdf

Reference60 articles.

1. Bi Z, Liu Y, Zhao Y, Yao Y, Wu R, Liu Q et al (2019) A dynamic reversible RNA N(6) -methyladenosine modification: current status and perspectives. J Cell Physiol 234(6):7948–7956

2. Bilusic M, Madan RA, Gulley JL (2017) Immunotherapy of prostate cancer: facts and hopes. Clin Cancer Res 23(22):6764–6770

3. Boettcher AN, Usman A, Morgans A, VanderWeele DJ, Sosman J, Wu JD (2019) Past, current, and future of immunotherapies for prostate cancer. Front Oncol 9:884

4. Byron SA, Van Keuren-Jensen KR, Engelthaler DM, Carpten JD, Craig DW (2016) Translating RNA sequencing into clinical diagnostics: opportunities and challenges. Nat Rev Genet 17(5):257–271

5. Cha HR, Lee JH, Ponnazhagan S (2020) Revisiting immunotherapy: a focus on prostate cancer. Can Res 80(8):1615–1623

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. From microscopes to molecules: The evolution of prostate cancer diagnostics;Cytojournal;2024-08-29

2. RNA N6-methyladenosine modifications in urological cancers: from mechanism to application;Nature Reviews Urology;2024-02-12

3. Prognostic signature analysis and survival prediction of esophageal cancer based on N6-methyladenosine associated lncRNAs;Briefings in Functional Genomics;2023-07-18

4. The m6A methylation landscape, molecular characterization and clinical relevance in prostate adenocarcinoma;Frontiers in Immunology;2023-03-23

5. Novel cuproptosis-related long non-coding RNA signature to predict prognosis in prostate carcinoma;BMC Cancer;2023-01-30